While there have been many sober warnings about AI and recursive self-improvement, Arianna Huffington argues that it is a ...

And that could be a good thing ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Your hard-earned money would be better spent elsewhere.

OpenAI has talked about how having an automated AI researcher was on its roadmap, and it’s shown the first glimpses of that ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

It’s become a trope in Silicon Valley to liken the rise of AI to t. Hardcore AI true-believers often say that the rise of ...

These aren't for the faint of heart.

Microsoft, meanwhile, is trying to turn the trend towards recursive self-improvement into a sales pitch for enterprise AI. In an X post earlier this month, company CEO Satya Nadella wrote that ...

Development of next-generation denoising image processing technology 'SHINE' completed; full-scale commercialization now underway ...